We partner with BioMed Central's open access journal, Molecular Neurodegeneration (MN), which is the official journal of BrightFocus. The open access publishing model provides free articles to the general public, as well as scientists, clinicians, and other healthcare practitioners.
MN publishes peer-reviewed, original scientific research on the causes of neurodegenerative diseases, such as Alzheimer's or Parkinson' and on the pre-clinical testing of potential therapies for these devastating diseases.
MN has an impact score of 8.274 (with a 5-year impact factor of 8.102, reflecting the sustained impact of our journal) and remains the highest ranked open access neuroscience journal in the Journal Citation Reports (JCR).
The 6th International Conference on Molecular Neurodegeneration (ICMN2020) to be held May 21-23, 2020 in Bangkok, Thailand, will offer a series of invited talks by well-renowned speakers to discuss Glial and Vascular Contributions to Neurodegenerative Diseases.
The combination of invited talks with abstract-selected short talks and poster presentations will provide excellent opportunities for productive discussions, networking, and collaboration to further our understanding on the genetic, cell and molecular processes responsible for the most common neurodegenerative disorders.